Global Fabry Disease Therapeutic Market Insights, Forecast to 2029
This report presents an overview of global market for Fabry Disease Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Fabry Disease Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fabry Disease Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fabry Disease Therapeutic revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Fabry Disease Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Fabry Disease Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amicus therapeutics, Takeda, Genzyme-Sanofi, Protalix, Sanofi-Aventis LLC, Novartis Pharmaceuticals, Pfizer, Bristol-Myers Squibb Company and GlaxoSmithKline plc, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Fabry Disease Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fabry Disease Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fabry Disease Therapeutic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Fabry Disease Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fabry Disease Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fabry Disease Therapeutic revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Fabry Disease Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Fabry Disease Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amicus therapeutics, Takeda, Genzyme-Sanofi, Protalix, Sanofi-Aventis LLC, Novartis Pharmaceuticals, Pfizer, Bristol-Myers Squibb Company and GlaxoSmithKline plc, etc.
By Company
- Amicus therapeutics
- Takeda
- Genzyme-Sanofi
- Protalix
- Sanofi-Aventis LLC
- Novartis Pharmaceuticals
- Pfizer
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Amgen Inc.
- Teva pharmaceutical Industries Ltd.
- Merc & Co.
- AbbVie Inc.
- Takeda Pharmaceutical Co. Ltd.
- Green Cross Corp.
- Enzyme Replacement Therapy
- Alternative therapies
- Hospitals
- Clinics
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Fabry Disease Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fabry Disease Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fabry Disease Therapeutic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fabry Disease Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Enzyme Replacement Therapy
1.2.3 Alternative therapies
1.3 Market by Application
1.3.1 Global Fabry Disease Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Fabry Disease Therapeutic Market Perspective (2018-2029)
2.2 Global Fabry Disease Therapeutic Growth Trends by Region
2.2.1 Fabry Disease Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fabry Disease Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Fabry Disease Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Fabry Disease Therapeutic Market Dynamics
2.3.1 Fabry Disease Therapeutic Industry Trends
2.3.2 Fabry Disease Therapeutic Market Drivers
2.3.3 Fabry Disease Therapeutic Market Challenges
2.3.4 Fabry Disease Therapeutic Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Fabry Disease Therapeutic by Players
3.1.1 Global Fabry Disease Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Fabry Disease Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Fabry Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Fabry Disease Therapeutic, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Fabry Disease Therapeutic Market Concentration Ratio
3.4.1 Global Fabry Disease Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fabry Disease Therapeutic Revenue in 2022
3.5 Global Key Players of Fabry Disease Therapeutic Head office and Area Served
3.6 Global Key Players of Fabry Disease Therapeutic, Product and Application
3.7 Global Key Players of Fabry Disease Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 FABRY DISEASE THERAPEUTIC BREAKDOWN DATA BY TYPE
4.1 Global Fabry Disease Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Fabry Disease Therapeutic Forecasted Market Size by Type (2024-2029)
5 FABRY DISEASE THERAPEUTIC BREAKDOWN DATA BY APPLICATION
5.1 Global Fabry Disease Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Fabry Disease Therapeutic Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Fabry Disease Therapeutic Market Size (2018-2029)
6.2 North America Fabry Disease Therapeutic Market Size by Type
6.2.1 North America Fabry Disease Therapeutic Market Size by Type (2018-2023)
6.2.2 North America Fabry Disease Therapeutic Market Size by Type (2024-2029)
6.2.3 North America Fabry Disease Therapeutic Market Share by Type (2018-2029)
6.3 North America Fabry Disease Therapeutic Market Size by Application
6.3.1 North America Fabry Disease Therapeutic Market Size by Application (2018-2023)
6.3.2 North America Fabry Disease Therapeutic Market Size by Application (2024-2029)
6.3.3 North America Fabry Disease Therapeutic Market Share by Application (2018-2029)
6.4 North America Fabry Disease Therapeutic Market Size by Country
6.4.1 North America Fabry Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Fabry Disease Therapeutic Market Size by Country (2018-2023)
6.4.3 North America Fabry Disease Therapeutic Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Fabry Disease Therapeutic Market Size (2018-2029)
7.2 Europe Fabry Disease Therapeutic Market Size by Type
7.2.1 Europe Fabry Disease Therapeutic Market Size by Type (2018-2023)
7.2.2 Europe Fabry Disease Therapeutic Market Size by Type (2024-2029)
7.2.3 Europe Fabry Disease Therapeutic Market Share by Type (2018-2029)
7.3 Europe Fabry Disease Therapeutic Market Size by Application
7.3.1 Europe Fabry Disease Therapeutic Market Size by Application (2018-2023)
7.3.2 Europe Fabry Disease Therapeutic Market Size by Application (2024-2029)
7.3.3 Europe Fabry Disease Therapeutic Market Share by Application (2018-2029)
7.4 Europe Fabry Disease Therapeutic Market Size by Country
7.4.1 Europe Fabry Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Fabry Disease Therapeutic Market Size by Country (2018-2023)
7.4.3 Europe Fabry Disease Therapeutic Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Fabry Disease Therapeutic Market Size (2018-2029)
8.2 China Fabry Disease Therapeutic Market Size by Type
8.2.1 China Fabry Disease Therapeutic Market Size by Type (2018-2023)
8.2.2 China Fabry Disease Therapeutic Market Size by Type (2024-2029)
8.2.3 China Fabry Disease Therapeutic Market Share by Type (2018-2029)
8.3 China Fabry Disease Therapeutic Market Size by Application
8.3.1 China Fabry Disease Therapeutic Market Size by Application (2018-2023)
8.3.2 China Fabry Disease Therapeutic Market Size by Application (2024-2029)
8.3.3 China Fabry Disease Therapeutic Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Fabry Disease Therapeutic Market Size (2018-2029)
9.2 Asia Fabry Disease Therapeutic Market Size by Type
9.2.1 Asia Fabry Disease Therapeutic Market Size by Type (2018-2023)
9.2.2 Asia Fabry Disease Therapeutic Market Size by Type (2024-2029)
9.2.3 Asia Fabry Disease Therapeutic Market Share by Type (2018-2029)
9.3 Asia Fabry Disease Therapeutic Market Size by Application
9.3.1 Asia Fabry Disease Therapeutic Market Size by Application (2018-2023)
9.3.2 Asia Fabry Disease Therapeutic Market Size by Application (2024-2029)
9.3.3 Asia Fabry Disease Therapeutic Market Share by Application (2018-2029)
9.4 Asia Fabry Disease Therapeutic Market Size by Region
9.4.1 Asia Fabry Disease Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Fabry Disease Therapeutic Market Size by Region (2018-2023)
9.4.3 Asia Fabry Disease Therapeutic Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Amicus therapeutics
11.1.1 Amicus therapeutics Company Details
11.1.2 Amicus therapeutics Business Overview
11.1.3 Amicus therapeutics Fabry Disease Therapeutic Introduction
11.1.4 Amicus therapeutics Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.1.5 Amicus therapeutics Recent Developments
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Fabry Disease Therapeutic Introduction
11.2.4 Takeda Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.2.5 Takeda Recent Developments
11.3 Genzyme-Sanofi
11.3.1 Genzyme-Sanofi Company Details
11.3.2 Genzyme-Sanofi Business Overview
11.3.3 Genzyme-Sanofi Fabry Disease Therapeutic Introduction
11.3.4 Genzyme-Sanofi Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.3.5 Genzyme-Sanofi Recent Developments
11.4 Protalix
11.4.1 Protalix Company Details
11.4.2 Protalix Business Overview
11.4.3 Protalix Fabry Disease Therapeutic Introduction
11.4.4 Protalix Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.4.5 Protalix Recent Developments
11.5 Sanofi-Aventis LLC
11.5.1 Sanofi-Aventis LLC Company Details
11.5.2 Sanofi-Aventis LLC Business Overview
11.5.3 Sanofi-Aventis LLC Fabry Disease Therapeutic Introduction
11.5.4 Sanofi-Aventis LLC Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.5.5 Sanofi-Aventis LLC Recent Developments
11.6 Novartis Pharmaceuticals
11.6.1 Novartis Pharmaceuticals Company Details
11.6.2 Novartis Pharmaceuticals Business Overview
11.6.3 Novartis Pharmaceuticals Fabry Disease Therapeutic Introduction
11.6.4 Novartis Pharmaceuticals Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.6.5 Novartis Pharmaceuticals Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Fabry Disease Therapeutic Introduction
11.7.4 Pfizer Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.7.5 Pfizer Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Details
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Fabry Disease Therapeutic Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 GlaxoSmithKline plc
11.9.1 GlaxoSmithKline plc Company Details
11.9.2 GlaxoSmithKline plc Business Overview
11.9.3 GlaxoSmithKline plc Fabry Disease Therapeutic Introduction
11.9.4 GlaxoSmithKline plc Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.9.5 GlaxoSmithKline plc Recent Developments
11.10 Amgen Inc.
11.10.1 Amgen Inc. Company Details
11.10.2 Amgen Inc. Business Overview
11.10.3 Amgen Inc. Fabry Disease Therapeutic Introduction
11.10.4 Amgen Inc. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.10.5 Amgen Inc. Recent Developments
11.11 Teva pharmaceutical Industries Ltd.
11.11.1 Teva pharmaceutical Industries Ltd. Company Details
11.11.2 Teva pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Introduction
11.11.4 Teva pharmaceutical Industries Ltd. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.11.5 Teva pharmaceutical Industries Ltd. Recent Developments
11.12 Merc & Co.
11.12.1 Merc & Co. Company Details
11.12.2 Merc & Co. Business Overview
11.12.3 Merc & Co. Fabry Disease Therapeutic Introduction
11.12.4 Merc & Co. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.12.5 Merc & Co. Recent Developments
11.13 AbbVie Inc.
11.13.1 AbbVie Inc. Company Details
11.13.2 AbbVie Inc. Business Overview
11.13.3 AbbVie Inc. Fabry Disease Therapeutic Introduction
11.13.4 AbbVie Inc. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.13.5 AbbVie Inc. Recent Developments
11.14 Takeda Pharmaceutical Co. Ltd.
11.14.1 Takeda Pharmaceutical Co. Ltd. Company Details
11.14.2 Takeda Pharmaceutical Co. Ltd. Business Overview
11.14.3 Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Introduction
11.14.4 Takeda Pharmaceutical Co. Ltd. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.14.5 Takeda Pharmaceutical Co. Ltd. Recent Developments
11.15 Green Cross Corp.
11.15.1 Green Cross Corp. Company Details
11.15.2 Green Cross Corp. Business Overview
11.15.3 Green Cross Corp. Fabry Disease Therapeutic Introduction
11.15.4 Green Cross Corp. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.15.5 Green Cross Corp. Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fabry Disease Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Enzyme Replacement Therapy
1.2.3 Alternative therapies
1.3 Market by Application
1.3.1 Global Fabry Disease Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Fabry Disease Therapeutic Market Perspective (2018-2029)
2.2 Global Fabry Disease Therapeutic Growth Trends by Region
2.2.1 Fabry Disease Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fabry Disease Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Fabry Disease Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Fabry Disease Therapeutic Market Dynamics
2.3.1 Fabry Disease Therapeutic Industry Trends
2.3.2 Fabry Disease Therapeutic Market Drivers
2.3.3 Fabry Disease Therapeutic Market Challenges
2.3.4 Fabry Disease Therapeutic Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Fabry Disease Therapeutic by Players
3.1.1 Global Fabry Disease Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Fabry Disease Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Fabry Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Fabry Disease Therapeutic, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Fabry Disease Therapeutic Market Concentration Ratio
3.4.1 Global Fabry Disease Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fabry Disease Therapeutic Revenue in 2022
3.5 Global Key Players of Fabry Disease Therapeutic Head office and Area Served
3.6 Global Key Players of Fabry Disease Therapeutic, Product and Application
3.7 Global Key Players of Fabry Disease Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 FABRY DISEASE THERAPEUTIC BREAKDOWN DATA BY TYPE
4.1 Global Fabry Disease Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Fabry Disease Therapeutic Forecasted Market Size by Type (2024-2029)
5 FABRY DISEASE THERAPEUTIC BREAKDOWN DATA BY APPLICATION
5.1 Global Fabry Disease Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Fabry Disease Therapeutic Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Fabry Disease Therapeutic Market Size (2018-2029)
6.2 North America Fabry Disease Therapeutic Market Size by Type
6.2.1 North America Fabry Disease Therapeutic Market Size by Type (2018-2023)
6.2.2 North America Fabry Disease Therapeutic Market Size by Type (2024-2029)
6.2.3 North America Fabry Disease Therapeutic Market Share by Type (2018-2029)
6.3 North America Fabry Disease Therapeutic Market Size by Application
6.3.1 North America Fabry Disease Therapeutic Market Size by Application (2018-2023)
6.3.2 North America Fabry Disease Therapeutic Market Size by Application (2024-2029)
6.3.3 North America Fabry Disease Therapeutic Market Share by Application (2018-2029)
6.4 North America Fabry Disease Therapeutic Market Size by Country
6.4.1 North America Fabry Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Fabry Disease Therapeutic Market Size by Country (2018-2023)
6.4.3 North America Fabry Disease Therapeutic Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Fabry Disease Therapeutic Market Size (2018-2029)
7.2 Europe Fabry Disease Therapeutic Market Size by Type
7.2.1 Europe Fabry Disease Therapeutic Market Size by Type (2018-2023)
7.2.2 Europe Fabry Disease Therapeutic Market Size by Type (2024-2029)
7.2.3 Europe Fabry Disease Therapeutic Market Share by Type (2018-2029)
7.3 Europe Fabry Disease Therapeutic Market Size by Application
7.3.1 Europe Fabry Disease Therapeutic Market Size by Application (2018-2023)
7.3.2 Europe Fabry Disease Therapeutic Market Size by Application (2024-2029)
7.3.3 Europe Fabry Disease Therapeutic Market Share by Application (2018-2029)
7.4 Europe Fabry Disease Therapeutic Market Size by Country
7.4.1 Europe Fabry Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Fabry Disease Therapeutic Market Size by Country (2018-2023)
7.4.3 Europe Fabry Disease Therapeutic Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Fabry Disease Therapeutic Market Size (2018-2029)
8.2 China Fabry Disease Therapeutic Market Size by Type
8.2.1 China Fabry Disease Therapeutic Market Size by Type (2018-2023)
8.2.2 China Fabry Disease Therapeutic Market Size by Type (2024-2029)
8.2.3 China Fabry Disease Therapeutic Market Share by Type (2018-2029)
8.3 China Fabry Disease Therapeutic Market Size by Application
8.3.1 China Fabry Disease Therapeutic Market Size by Application (2018-2023)
8.3.2 China Fabry Disease Therapeutic Market Size by Application (2024-2029)
8.3.3 China Fabry Disease Therapeutic Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Fabry Disease Therapeutic Market Size (2018-2029)
9.2 Asia Fabry Disease Therapeutic Market Size by Type
9.2.1 Asia Fabry Disease Therapeutic Market Size by Type (2018-2023)
9.2.2 Asia Fabry Disease Therapeutic Market Size by Type (2024-2029)
9.2.3 Asia Fabry Disease Therapeutic Market Share by Type (2018-2029)
9.3 Asia Fabry Disease Therapeutic Market Size by Application
9.3.1 Asia Fabry Disease Therapeutic Market Size by Application (2018-2023)
9.3.2 Asia Fabry Disease Therapeutic Market Size by Application (2024-2029)
9.3.3 Asia Fabry Disease Therapeutic Market Share by Application (2018-2029)
9.4 Asia Fabry Disease Therapeutic Market Size by Region
9.4.1 Asia Fabry Disease Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Fabry Disease Therapeutic Market Size by Region (2018-2023)
9.4.3 Asia Fabry Disease Therapeutic Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Amicus therapeutics
11.1.1 Amicus therapeutics Company Details
11.1.2 Amicus therapeutics Business Overview
11.1.3 Amicus therapeutics Fabry Disease Therapeutic Introduction
11.1.4 Amicus therapeutics Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.1.5 Amicus therapeutics Recent Developments
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Fabry Disease Therapeutic Introduction
11.2.4 Takeda Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.2.5 Takeda Recent Developments
11.3 Genzyme-Sanofi
11.3.1 Genzyme-Sanofi Company Details
11.3.2 Genzyme-Sanofi Business Overview
11.3.3 Genzyme-Sanofi Fabry Disease Therapeutic Introduction
11.3.4 Genzyme-Sanofi Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.3.5 Genzyme-Sanofi Recent Developments
11.4 Protalix
11.4.1 Protalix Company Details
11.4.2 Protalix Business Overview
11.4.3 Protalix Fabry Disease Therapeutic Introduction
11.4.4 Protalix Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.4.5 Protalix Recent Developments
11.5 Sanofi-Aventis LLC
11.5.1 Sanofi-Aventis LLC Company Details
11.5.2 Sanofi-Aventis LLC Business Overview
11.5.3 Sanofi-Aventis LLC Fabry Disease Therapeutic Introduction
11.5.4 Sanofi-Aventis LLC Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.5.5 Sanofi-Aventis LLC Recent Developments
11.6 Novartis Pharmaceuticals
11.6.1 Novartis Pharmaceuticals Company Details
11.6.2 Novartis Pharmaceuticals Business Overview
11.6.3 Novartis Pharmaceuticals Fabry Disease Therapeutic Introduction
11.6.4 Novartis Pharmaceuticals Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.6.5 Novartis Pharmaceuticals Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Fabry Disease Therapeutic Introduction
11.7.4 Pfizer Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.7.5 Pfizer Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Details
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Fabry Disease Therapeutic Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 GlaxoSmithKline plc
11.9.1 GlaxoSmithKline plc Company Details
11.9.2 GlaxoSmithKline plc Business Overview
11.9.3 GlaxoSmithKline plc Fabry Disease Therapeutic Introduction
11.9.4 GlaxoSmithKline plc Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.9.5 GlaxoSmithKline plc Recent Developments
11.10 Amgen Inc.
11.10.1 Amgen Inc. Company Details
11.10.2 Amgen Inc. Business Overview
11.10.3 Amgen Inc. Fabry Disease Therapeutic Introduction
11.10.4 Amgen Inc. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.10.5 Amgen Inc. Recent Developments
11.11 Teva pharmaceutical Industries Ltd.
11.11.1 Teva pharmaceutical Industries Ltd. Company Details
11.11.2 Teva pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Introduction
11.11.4 Teva pharmaceutical Industries Ltd. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.11.5 Teva pharmaceutical Industries Ltd. Recent Developments
11.12 Merc & Co.
11.12.1 Merc & Co. Company Details
11.12.2 Merc & Co. Business Overview
11.12.3 Merc & Co. Fabry Disease Therapeutic Introduction
11.12.4 Merc & Co. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.12.5 Merc & Co. Recent Developments
11.13 AbbVie Inc.
11.13.1 AbbVie Inc. Company Details
11.13.2 AbbVie Inc. Business Overview
11.13.3 AbbVie Inc. Fabry Disease Therapeutic Introduction
11.13.4 AbbVie Inc. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.13.5 AbbVie Inc. Recent Developments
11.14 Takeda Pharmaceutical Co. Ltd.
11.14.1 Takeda Pharmaceutical Co. Ltd. Company Details
11.14.2 Takeda Pharmaceutical Co. Ltd. Business Overview
11.14.3 Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Introduction
11.14.4 Takeda Pharmaceutical Co. Ltd. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.14.5 Takeda Pharmaceutical Co. Ltd. Recent Developments
11.15 Green Cross Corp.
11.15.1 Green Cross Corp. Company Details
11.15.2 Green Cross Corp. Business Overview
11.15.3 Green Cross Corp. Fabry Disease Therapeutic Introduction
11.15.4 Green Cross Corp. Revenue in Fabry Disease Therapeutic Business (2018-2023)
11.15.5 Green Cross Corp. Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Fabry Disease Therapeutic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Alternative therapies
Table 4. Global Fabry Disease Therapeutic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Fabry Disease Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Fabry Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Fabry Disease Therapeutic Market Share by Region (2018-2023)
Table 8. Global Fabry Disease Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Fabry Disease Therapeutic Market Share by Region (2024-2029)
Table 10. Fabry Disease Therapeutic Market Trends
Table 11. Fabry Disease Therapeutic Market Drivers
Table 12. Fabry Disease Therapeutic Market Challenges
Table 13. Fabry Disease Therapeutic Market Restraints
Table 14. Global Fabry Disease Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Fabry Disease Therapeutic Revenue Share by Players (2018-2023)
Table 16. Global Top Fabry Disease Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Therapeutic as of 2022)
Table 17. Global Fabry Disease Therapeutic Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Fabry Disease Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Fabry Disease Therapeutic, Headquarters and Area Served
Table 20. Global Key Players of Fabry Disease Therapeutic, Product and Application
Table 21. Global Key Players of Fabry Disease Therapeutic, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Fabry Disease Therapeutic Revenue Market Share by Type (2018-2023)
Table 25. Global Fabry Disease Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Fabry Disease Therapeutic Revenue Market Share by Type (2024-2029)
Table 27. Global Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Fabry Disease Therapeutic Revenue Share by Application (2018-2023)
Table 29. Global Fabry Disease Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Fabry Disease Therapeutic Revenue Share by Application (2024-2029)
Table 31. North America Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Fabry Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Fabry Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Fabry Disease Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Fabry Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Fabry Disease Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Fabry Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 63. Amicus therapeutics Company Details
Table 64. Amicus therapeutics Business Overview
Table 65. Amicus therapeutics Fabry Disease Therapeutic Product
Table 66. Amicus therapeutics Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 67. Amicus therapeutics Recent Developments
Table 68. Takeda Company Details
Table 69. Takeda Business Overview
Table 70. Takeda Fabry Disease Therapeutic Product
Table 71. Takeda Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 72. Takeda Recent Developments
Table 73. Genzyme-Sanofi Company Details
Table 74. Genzyme-Sanofi Business Overview
Table 75. Genzyme-Sanofi Fabry Disease Therapeutic Product
Table 76. Genzyme-Sanofi Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 77. Genzyme-Sanofi Recent Developments
Table 78. Protalix Company Details
Table 79. Protalix Business Overview
Table 80. Protalix Fabry Disease Therapeutic Product
Table 81. Protalix Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 82. Protalix Recent Developments
Table 83. Sanofi-Aventis LLC Company Details
Table 84. Sanofi-Aventis LLC Business Overview
Table 85. Sanofi-Aventis LLC Fabry Disease Therapeutic Product
Table 86. Sanofi-Aventis LLC Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 87. Sanofi-Aventis LLC Recent Developments
Table 88. Novartis Pharmaceuticals Company Details
Table 89. Novartis Pharmaceuticals Business Overview
Table 90. Novartis Pharmaceuticals Fabry Disease Therapeutic Product
Table 91. Novartis Pharmaceuticals Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 92. Novartis Pharmaceuticals Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Fabry Disease Therapeutic Product
Table 96. Pfizer Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 97. Pfizer Recent Developments
Table 98. Bristol-Myers Squibb Company Company Details
Table 99. Bristol-Myers Squibb Company Business Overview
Table 100. Bristol-Myers Squibb Company Fabry Disease Therapeutic Product
Table 101. Bristol-Myers Squibb Company Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 102. Bristol-Myers Squibb Company Recent Developments
Table 103. GlaxoSmithKline plc Company Details
Table 104. GlaxoSmithKline plc Business Overview
Table 105. GlaxoSmithKline plc Fabry Disease Therapeutic Product
Table 106. GlaxoSmithKline plc Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 107. GlaxoSmithKline plc Recent Developments
Table 108. Amgen Inc. Company Details
Table 109. Amgen Inc. Business Overview
Table 110. Amgen Inc. Fabry Disease Therapeutic Product
Table 111. Amgen Inc. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 112. Amgen Inc. Recent Developments
Table 113. Teva pharmaceutical Industries Ltd. Company Details
Table 114. Teva pharmaceutical Industries Ltd. Business Overview
Table 115. Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Product
Table 116. Teva pharmaceutical Industries Ltd. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 117. Teva pharmaceutical Industries Ltd. Recent Developments
Table 118. Merc & Co. Company Details
Table 119. Merc & Co. Business Overview
Table 120. Merc & Co. Fabry Disease Therapeutic Product
Table 121. Merc & Co. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 122. Merc & Co. Recent Developments
Table 123. AbbVie Inc. Company Details
Table 124. AbbVie Inc. Business Overview
Table 125. AbbVie Inc. Fabry Disease Therapeutic Product
Table 126. AbbVie Inc. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 127. AbbVie Inc. Recent Developments
Table 128. Takeda Pharmaceutical Co. Ltd. Company Details
Table 129. Takeda Pharmaceutical Co. Ltd. Business Overview
Table 130. Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Product
Table 131. Takeda Pharmaceutical Co. Ltd. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 132. Takeda Pharmaceutical Co. Ltd. Recent Developments
Table 133. Green Cross Corp. Company Details
Table 134. Green Cross Corp. Business Overview
Table 135. Green Cross Corp. Fabry Disease Therapeutic Product
Table 136. Green Cross Corp. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 137. Green Cross Corp. Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 1. Global Fabry Disease Therapeutic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Alternative therapies
Table 4. Global Fabry Disease Therapeutic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Fabry Disease Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Fabry Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Fabry Disease Therapeutic Market Share by Region (2018-2023)
Table 8. Global Fabry Disease Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Fabry Disease Therapeutic Market Share by Region (2024-2029)
Table 10. Fabry Disease Therapeutic Market Trends
Table 11. Fabry Disease Therapeutic Market Drivers
Table 12. Fabry Disease Therapeutic Market Challenges
Table 13. Fabry Disease Therapeutic Market Restraints
Table 14. Global Fabry Disease Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Fabry Disease Therapeutic Revenue Share by Players (2018-2023)
Table 16. Global Top Fabry Disease Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Therapeutic as of 2022)
Table 17. Global Fabry Disease Therapeutic Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Fabry Disease Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Fabry Disease Therapeutic, Headquarters and Area Served
Table 20. Global Key Players of Fabry Disease Therapeutic, Product and Application
Table 21. Global Key Players of Fabry Disease Therapeutic, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Fabry Disease Therapeutic Revenue Market Share by Type (2018-2023)
Table 25. Global Fabry Disease Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Fabry Disease Therapeutic Revenue Market Share by Type (2024-2029)
Table 27. Global Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Fabry Disease Therapeutic Revenue Share by Application (2018-2023)
Table 29. Global Fabry Disease Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Fabry Disease Therapeutic Revenue Share by Application (2024-2029)
Table 31. North America Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Fabry Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Fabry Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Fabry Disease Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Fabry Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Fabry Disease Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Fabry Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 63. Amicus therapeutics Company Details
Table 64. Amicus therapeutics Business Overview
Table 65. Amicus therapeutics Fabry Disease Therapeutic Product
Table 66. Amicus therapeutics Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 67. Amicus therapeutics Recent Developments
Table 68. Takeda Company Details
Table 69. Takeda Business Overview
Table 70. Takeda Fabry Disease Therapeutic Product
Table 71. Takeda Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 72. Takeda Recent Developments
Table 73. Genzyme-Sanofi Company Details
Table 74. Genzyme-Sanofi Business Overview
Table 75. Genzyme-Sanofi Fabry Disease Therapeutic Product
Table 76. Genzyme-Sanofi Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 77. Genzyme-Sanofi Recent Developments
Table 78. Protalix Company Details
Table 79. Protalix Business Overview
Table 80. Protalix Fabry Disease Therapeutic Product
Table 81. Protalix Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 82. Protalix Recent Developments
Table 83. Sanofi-Aventis LLC Company Details
Table 84. Sanofi-Aventis LLC Business Overview
Table 85. Sanofi-Aventis LLC Fabry Disease Therapeutic Product
Table 86. Sanofi-Aventis LLC Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 87. Sanofi-Aventis LLC Recent Developments
Table 88. Novartis Pharmaceuticals Company Details
Table 89. Novartis Pharmaceuticals Business Overview
Table 90. Novartis Pharmaceuticals Fabry Disease Therapeutic Product
Table 91. Novartis Pharmaceuticals Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 92. Novartis Pharmaceuticals Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Fabry Disease Therapeutic Product
Table 96. Pfizer Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 97. Pfizer Recent Developments
Table 98. Bristol-Myers Squibb Company Company Details
Table 99. Bristol-Myers Squibb Company Business Overview
Table 100. Bristol-Myers Squibb Company Fabry Disease Therapeutic Product
Table 101. Bristol-Myers Squibb Company Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 102. Bristol-Myers Squibb Company Recent Developments
Table 103. GlaxoSmithKline plc Company Details
Table 104. GlaxoSmithKline plc Business Overview
Table 105. GlaxoSmithKline plc Fabry Disease Therapeutic Product
Table 106. GlaxoSmithKline plc Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 107. GlaxoSmithKline plc Recent Developments
Table 108. Amgen Inc. Company Details
Table 109. Amgen Inc. Business Overview
Table 110. Amgen Inc. Fabry Disease Therapeutic Product
Table 111. Amgen Inc. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 112. Amgen Inc. Recent Developments
Table 113. Teva pharmaceutical Industries Ltd. Company Details
Table 114. Teva pharmaceutical Industries Ltd. Business Overview
Table 115. Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Product
Table 116. Teva pharmaceutical Industries Ltd. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 117. Teva pharmaceutical Industries Ltd. Recent Developments
Table 118. Merc & Co. Company Details
Table 119. Merc & Co. Business Overview
Table 120. Merc & Co. Fabry Disease Therapeutic Product
Table 121. Merc & Co. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 122. Merc & Co. Recent Developments
Table 123. AbbVie Inc. Company Details
Table 124. AbbVie Inc. Business Overview
Table 125. AbbVie Inc. Fabry Disease Therapeutic Product
Table 126. AbbVie Inc. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 127. AbbVie Inc. Recent Developments
Table 128. Takeda Pharmaceutical Co. Ltd. Company Details
Table 129. Takeda Pharmaceutical Co. Ltd. Business Overview
Table 130. Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Product
Table 131. Takeda Pharmaceutical Co. Ltd. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 132. Takeda Pharmaceutical Co. Ltd. Recent Developments
Table 133. Green Cross Corp. Company Details
Table 134. Green Cross Corp. Business Overview
Table 135. Green Cross Corp. Fabry Disease Therapeutic Product
Table 136. Green Cross Corp. Revenue in Fabry Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 137. Green Cross Corp. Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Fabry Disease Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Fabry Disease Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Enzyme Replacement Therapy Features
Figure 4. Alternative therapies Features
Figure 5. Global Fabry Disease Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Fabry Disease Therapeutic Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Fabry Disease Therapeutic Report Years Considered
Figure 11. Global Fabry Disease Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Fabry Disease Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Fabry Disease Therapeutic Market Share by Region: 2022 VS 2029
Figure 14. Global Fabry Disease Therapeutic Market Share by Players in 2022
Figure 15. Global Top Fabry Disease Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Therapeutic as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Fabry Disease Therapeutic Revenue in 2022
Figure 17. North America Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 19. North America Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 20. North America Fabry Disease Therapeutic Market Share by Country (2018-2029)
Figure 21. United States Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Fabry Disease Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 25. Europe Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 26. Europe Fabry Disease Therapeutic Market Share by Country (2018-2029)
Figure 27. Germany Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Fabry Disease Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 35. China Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 36. Asia Fabry Disease Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 38. Asia Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 39. Asia Fabry Disease Therapeutic Market Share by Region (2018-2029)
Figure 40. Japan Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Country (2018-2029)
Figure 50. Brazil Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Amicus therapeutics Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 57. Takeda Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 58. Genzyme-Sanofi Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 59. Protalix Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 60. Sanofi-Aventis LLC Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 61. Novartis Pharmaceuticals Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 62. Pfizer Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 64. GlaxoSmithKline plc Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 65. Amgen Inc. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 66. Teva pharmaceutical Industries Ltd. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 67. Merc & Co. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 68. AbbVie Inc. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 69. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 70. Green Cross Corp. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Figure 1. Global Fabry Disease Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Fabry Disease Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Enzyme Replacement Therapy Features
Figure 4. Alternative therapies Features
Figure 5. Global Fabry Disease Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Fabry Disease Therapeutic Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Fabry Disease Therapeutic Report Years Considered
Figure 11. Global Fabry Disease Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Fabry Disease Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Fabry Disease Therapeutic Market Share by Region: 2022 VS 2029
Figure 14. Global Fabry Disease Therapeutic Market Share by Players in 2022
Figure 15. Global Top Fabry Disease Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Therapeutic as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Fabry Disease Therapeutic Revenue in 2022
Figure 17. North America Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 19. North America Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 20. North America Fabry Disease Therapeutic Market Share by Country (2018-2029)
Figure 21. United States Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Fabry Disease Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 25. Europe Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 26. Europe Fabry Disease Therapeutic Market Share by Country (2018-2029)
Figure 27. Germany Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Fabry Disease Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 35. China Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 36. Asia Fabry Disease Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 38. Asia Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 39. Asia Fabry Disease Therapeutic Market Share by Region (2018-2029)
Figure 40. Japan Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Fabry Disease Therapeutic Market Share by Country (2018-2029)
Figure 50. Brazil Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Fabry Disease Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Amicus therapeutics Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 57. Takeda Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 58. Genzyme-Sanofi Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 59. Protalix Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 60. Sanofi-Aventis LLC Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 61. Novartis Pharmaceuticals Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 62. Pfizer Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 64. GlaxoSmithKline plc Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 65. Amgen Inc. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 66. Teva pharmaceutical Industries Ltd. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 67. Merc & Co. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 68. AbbVie Inc. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 69. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 70. Green Cross Corp. Revenue Growth Rate in Fabry Disease Therapeutic Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
